| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | 1 | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | 1 | 2 | 1 | — | 3 | — | — | 1 | — |
| total | individual payouts | |
|---|---|---|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 0.95 |
—
—
—
|
| 2025 | 0.89 |
—
—
—
—
|
| 2024 | 0.88 |
—
—
—
—
|
| 2023 | 0.88 |
—
—
—
—
|
| 2022 | 0.88 |
—
—
—
—
|
| 2021 | 0.88 |
—
—
—
—
|
| 2020 | 0.88 |
—
—
—
—
|
| 2019 | 0.87 |
—
—
—
—
|
| 2018 | 0.80 |
—
—
—
—
|
| 2017 | 0.73 |
—
—
—
—
|
| 2016 | 0.71 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 801.35 | 1,092.03 | 1,070.72 | 881.20 |
| Receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 13,133.76 | 14,021.47 | 20,089.76 | 20,022.96 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 14,076.79 | 14,572.61 | 21,473.07 | 21,701.05 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 14,384.36 | 14,680.63 | 22,028.84 | 22,016.28 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 388.39 | 391.63 | — | — |
—
|
| ’25 | 256.73 | 392.23 | 397.12 | 398.06 |
1,444.14
|
| ’24 | 254.56 | 258.97 | 318.34 | 259.56 |
1,091.44
|
| ’23 | 221.34 | 214.39 | 243.88 | 230.79 |
910.39
|
| ’22 | 147.65 | 160.63 | 184.32 | 198.46 |
691.06
|
| ’21 | 202.80 | 168.60 | 164.77 | 159.50 |
695.67
|
| ’20 | 167.74 | 188.13 | 193.01 | 184.79 |
733.66
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 100.06 | 82.43 | — | — |
—
|
| ’25 | 50.10 | (30.56) | 144.80 | 107.14 |
271.47
|
| ’24 | 65.06 | (49.08) | (1.66) | 92.10 |
106.42
|
| ’23 | (7.38) | (24.16) | 79.66 | 100.43 |
148.55
|
| ’22 | 205.82 | 143.89 | 113.40 | 110.94 |
574.05
|
| ’21 | (56.79) | 106.37 | 40.59 | 52.49 |
142.66
|
| ’20 | (123.00) | 177.91 | (10.87) | 38.20 |
82.24
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 99.89 | 82.26 | — | — |
—
|
| ’25 | 47.29 | (20.28) | 130.30 | 117.09 |
274.41
|
| ’24 | 62.15 | (51.49) | 18.07 | 90.75 |
119.48
|
| ’23 | (14.97) | (28.09) | 77.63 | 96.41 |
130.98
|
| ’22 | 204.84 | 141.46 | 110.12 | 107.60 |
564.02
|
| ’21 | (57.42) | 106.14 | 37.45 | 52.13 |
138.30
|
| ’20 | (124.17) | 177.46 | (10.04) | 19.17 |
62.41
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.94 | 0.94 | — | — |
—
|
| ’25 | 0.65 | 0.01 | 0.63 | 0.83 |
2.07
|
| ’24 | 0.70 | 0.69 | 1.18 | 0.70 |
3.27
|
| ’23 | 0.82 | 0.51 | 0.75 | 0.50 |
2.56
|
| ’22 | 0.60 | 0.71 | 0.83 | 0.82 |
2.95
|
| ’21 | 1.02 | 0.72 | 0.71 | 0.66 |
3.12
|
| ’20 | 0.04 | 0.36 | 0.53 | 0.56 |
1.48
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 27.61 | 22.99 | 27.98 | 26.97 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 41.77 | 38.41 | 39.47 | 40.40 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,334 | 2,300 | 2,200 | 3,000 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.30 | 0.40 | 0.50 | 0.48 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 691.06 | 910.39 | 1,091.44 | 1,444.14 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 91.24% | 69.46% | 65.59% | 68.27% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 211.31 | 177.19 | 244.97 | 226.73 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 30.58% | 19.46% | 22.44% | 15.70% | ‡‡‡ | ‡‡‡ | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 166.07 | 144.68 | 195.46 | 181.27 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 42.74 | 35.23 | 32.28 | 16.21 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.36 | 16.23 | 18.39 | 16.61 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 2.97 | 2.58 | 3.29 | 2.09 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.27 | 2.65 | 1.79 | 3.12 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.18) | (0.31) | 0.22 | 0.03 | ‡‡‡ | ‡‡‡ | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.09 | 2.33 | 2.01 | 3.16 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 38.21 | 40.95 | 45.13 | 44.68 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 55.91 | 56.10 | 59.35 | 86.94 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.60 | 13.03 | 10.93 | 16.54 | ‡‡‡‡ | ‡‡‡‡ | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.03 | 2.07 | 1.94 | 2.12 | ‡‡‡ | ‡‡‡ | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.98 | 0.82 | 0.79 | 0.79 | ‡‡‡ | ‡‡‡ | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.86 | 1.78 | 1.44 | 1.80 | ‡‡‡ | ‡‡‡ | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.72 | 12.39 | 16.26 | 9.47 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 574.05 | 148.55 | 106.42 | 271.47 | ‡‡‡ | ‡‡‡ | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (10.03) | (17.58) | 13.06 | 2.94 | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 564.02 | 130.98 | 119.48 | 274.41 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2,126.89) | (1,250.60) | (659.16) | (1,939.08) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,148.13 | 429.40 | 430.61 | 499.76 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 572.14 | (371.95) | (661.42) | (570.96) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,136.02 | 2,297.38 | 2,678.32 | 3,884.91 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.98% | 0.84% | 1.10% | 0.81% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.93% | 5.75% | 8.00% | 5.21% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.64% | 6.53% | 7.86% | 5.52% | — | — | — |
ROE
|
Renasant Corporation (RNST), a Southeast-focused regional bank, has delivered explosive revenue growth of 134% since 2016, reaching $1.09 billion in 2024, propelled by strategic acquisitions that boosted revenue per employee 109% despite a 55% share count surge. This expansion has weathered sector storms like the 2023 banking crisis, with efficiency gains and a conservative loan mix shining through, though post-merger dilution has tempered per-share metrics and pressured gross margins down 30% relatively.
Profitability remains resilient—net income up 35% to $195 million and EPS at $3.29 (27% YoY)—underpinning a rock-solid balance sheet with $2.68 billion in equity (negative net debt) and ROIC spiking to 8%. Valuations scream value: PE at 10.9x (vs. 19x avg), PS at 1.94x (half historical norm), and PB at 0.79x, trading near stress-test lows amid analyst forecasts for EPS acceleration to $3.84 by 2027.
Merger synergies could unlock 10-15% annual EPS compounding and 20-30% stock rerating by 2026, per projections, with insider buys signaling board confidence despite routine sells. Risks like rate cuts or CRE exposure loom, but RNST’s fortress balance sheet positions it as a compelling value compounder—dive into the full analysis for the data-driven buy case.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.